EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing Drug Resistance Detection: Comparative Analysis Using Short-Read and Long-Read Next-Generation Sequencing Technologies

Julie Martinez, Rezak Drali, Amira Doudou, Chalom Sayada, Ronan Boulmé, Dimitri Gonzalez, Laurent Deblir, Matthieu Barralon, Jérome Wautrin, Jonathan Porzio, Arnaud Reffay, Mohamed Errafyqy und 5 weitere

LabMed · 2025

DOI: 10.3390/labmed2030014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LabMed, 2025. Verfasst von Julie Martinez und 16 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, antiviral therapy has proved crucial in the treatment of infectious diseases, particularly infections by highly variable viruses such as human immunodeficiency virus, hepatitis B, hepatitis C, SARS-CoV-2 or bacteria such as Mycobacterium tuberculosis. Under the effect of selection pressure, this variability induces mutations that lead to resistance to antiviral and antibacterial drugs, and thus to escape from treatment. The use of Advanced Biological Laboratories (ABL) assays technology combined with next-generation sequencing (NGS) and automatized software to detect majority and minority variants involved in treatment resistance has become a mainstay for establishing therapeutic strategies. The present study demonstrated high concordance between majority and minority subtypes and mutations identified in 15 samples across four NGS platforms: ISeq100 (Illumina (San Diego, CA, USA)), MiSeq (Illumina), DNBSEQ-G400 (MGI (Santa Clara, CA, USA)) and Mk1C MinION (Oxford Nanopore (Oxford Science Park, UK)). However, nanopore technology showed a higher number of minority mutations (

Zitieren

APA

Martinez, J., Drali, R., Doudou, A., Sayada, C., Boulmé, R., Gonzalez, D., Deblir, L., Barralon, M., Wautrin, J., Porzio, J., Reffay, A., Errafyqy, M., Kolsch, J., Léonard, J., Zuco, G., Modol, A., & Mohamed, S. (2025). Advancing Drug Resistance Detection: Comparative Analysis Using Short-Read and Long-Read Next-Generation Sequencing Technologies. LabMed. https://doi.org/10.3390/labmed2030014

Vancouver

Martinez J, Drali R, Doudou A, Sayada C, Boulmé R, Gonzalez D, et al. Advancing Drug Resistance Detection: Comparative Analysis Using Short-Read and Long-Read Next-Generation Sequencing Technologies. LabMed. 2025. doi:10.3390/labmed2030014

BibTeX
@article{Martinez2025,
  author = {Martinez, Julie and Drali, Rezak and Doudou, Amira and Sayada, Chalom and Boulmé, Ronan and Gonzalez, Dimitri and Deblir, Laurent and Barralon, Matthieu and Wautrin, Jérome and Porzio, Jonathan and Reffay, Arnaud and Errafyqy, Mohamed and Kolsch, Jonathan and Léonard, Jonathan and Zuco, Giuseppina and Modol, Aitor and Mohamed, Sofiane},
  title = {Advancing Drug Resistance Detection: Comparative Analysis Using Short-Read and Long-Read Next-Generation Sequencing Technologies},
  journal = {LabMed},
  year = {2025},
  doi = {10.3390/labmed2030014}
}
Kostenlos starten →